Can a lobbying push led by veterans help MDMA get approved for PTSD treatment?
MDMA-assisted therapy for PTSD is under FDA review, with veterans and various advocates pushing for its approval against initial skepticism and setbacks.
Psychedelic drug MDMA could be 'a new avenue of treatment' as FDA begins its first-ever review
A panel will discuss MDMA therapy for PTSD, marking progress in FDA approval process.
FDA Rejects the Psychedelic MDMA as a PTSD Treatment
FDA declined approval of MDMA for PTSD therapy, citing data limitations and requesting more studies.
FDA rejects psychedelic drug MDMA as a treatment for PTSD
FDA declined to approve MDMA for PTSD therapy, setback for psychedelic drugs in mental health
I did MDMA therapy before it was legal. For me it was transformative but I have some concerns | Rebecca Huntley
Australia is leading the way in MDMA therapy for PTSD after decades of prohibition, now authorized for prescribing in some cases.
Can a lobbying push led by veterans help MDMA get approved for PTSD treatment?
MDMA-assisted therapy for PTSD is under FDA review, with veterans and various advocates pushing for its approval against initial skepticism and setbacks.
Psychedelic drug MDMA could be 'a new avenue of treatment' as FDA begins its first-ever review
A panel will discuss MDMA therapy for PTSD, marking progress in FDA approval process.
FDA Rejects the Psychedelic MDMA as a PTSD Treatment
FDA declined approval of MDMA for PTSD therapy, citing data limitations and requesting more studies.
FDA rejects psychedelic drug MDMA as a treatment for PTSD
FDA declined to approve MDMA for PTSD therapy, setback for psychedelic drugs in mental health
I did MDMA therapy before it was legal. For me it was transformative but I have some concerns | Rebecca Huntley
Australia is leading the way in MDMA therapy for PTSD after decades of prohibition, now authorized for prescribing in some cases.
MDMA for PTSD: Three studies retracted on heels of FDA rejection
The FDA rejected MDMA therapy for PTSD due to concerns about flawed clinical trials and biases in people involved, prompting retraction of supporting studies.